Detalhe da pesquisa
1.
Practice Variations in Managing Infantile Hemangiomas.
J Pediatr Hematol Oncol
; 45(8): 452-460, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749794
2.
Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.
Pediatr Blood Cancer
; 61(12): 2319-20, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25154390
3.
Gene expression patterns in peripheral blood cells associated with radiographic severity in African Americans with early rheumatoid arthritis.
Rheumatol Int
; 33(1): 129-37, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22238028
4.
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL.
Oncotarget
; 11(32): 3035-3047, 2020 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850008
5.
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
Oncoimmunology
; 8(1): e1512455, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546948
6.
Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model.
Oncotarget
; 9(11): 9776-9788, 2018 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29515770
7.
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL.
Oncotarget
; 8(17): 27839-27853, 2017 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427156